KIT and systemic mastocytosis: The World Health Organization (WHO) defines SM based on specific diagnostic criteria, including dense mast cell infiltrates in extracutaneous organs, marrow, or blood, as well as minor criteria such as atypical mast cell morphology, KIT D816V mutations, CD25 expression, and persistently elevated serum tryptase levels.